Retroviral protease inhibitors
US5475013A · kind A · utility
22Cited by
15References
57Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 1992 |
| Grant date | Dec 12, 1995 |
| Priority date | — |
| Expiry date | May 20, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Urea-containing hydroxyethylamine peptide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.